Sat, Jan 31, 2015, 4:08 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

pSivida Corp. Message Board

  • icdcweb icdcweb Jul 12, 2013 5:24 PM Flag

    Website is down!

    I went to look at Psivida website to read up on their pipeline and it's down. Well that can't be good! I wonder how long the site has been down today??

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Stop imagining bad news...they have to update the site to reflect the 1st P3 trial for the new micro insert lens
      which they received permission from the FDA after a P1/2 trial was impressive. There were three large trades
      which accounted for most of the volume on the way down before the stick stabilized....most likely stop losses
      were taken out. ALIM is a better reference for PSDV and that continues to go up, and since PSDV has not licensed the micro insert for the P3 indications,people may think that they will need to raise capital.My belief is that once Iluvien is approved by trhe FDA in October, then ALIM will pay PSDV 25 million dollars and will
      start to pay 20 of net sales from the EU to PSDV also. And when they new improved micro insert gets approved it will also become the preferred method for the Retisert drug licensed to B&L at a higher licensing % plus PSDV will have the upper hand for the larger share of the licensing % for the new indication uses. Lastly if all goes as planned,you could see Regeneron come in and make PSDV an offer they can't refuse because it's method of delivery using a micro lens is infinetely superior to sticking a needle in peoples eyes to deliver their Eylea drug. I plan on loading up on PSDV as long as the market keeps the price below $ 3.50

      Sentiment: Strong Buy

 
PSDV
3.87-0.05(-1.28%)Jan 30 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.